L ike many rare diseases, fibrolamellar hepatocellular carcinoma (FLC) mounts a ferocious attack against an unlucky few—in this case, children, adolescents, and young adults. Because its ...

Background Fibrolamellar carcinoma (FLC), a rare and fatal liver cancer lacking effective drug therapy, is driven by the DNAJ ...

Long-term use of statins may delay or deflect the development of hepatocellular carcinoma in adults with chronic liver disease, as well as in the general population, emerging research, including ...

Other areas of expertise include analyzing treatment outcomes data for patients with gastrointestinal cancers, as well as the identification of new treatments for fibrolamellar hepatocellular ...

Family members, friends and colleagues are rallying behind a Carson City Sheriff’s Office dispatcher who was recently diagnosed with a rare form of cancer. Haylee Busby, 20, a 2022 Carson […] ...

liver cancer multiomics analysis reveals that various disruptions in protein kinase A pathways collectively contribute to the development of fibrolamellar hepatocellular carcinoma. Key Market ...

Effort will support a new clinical trial for fibrolamellar carcinoma, a rare cancer that primarily impacts children and young adults GREENWICH, CT, UNITED STATES, April 21, 2025 /EINPresswire.com ...